
The average Pharmavite Investor Relations in Los Angeles earns an estimated $82,288 annually. Pharmavite's Investor Relations compensation is $357 more than the US average for a Investor Relations.
Last updated 4 months ago.
The majority of Investor Relations at Pharmavite believe they're compensated fairly. 50% of Investor Relations at Pharmavite say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Pharmavite